SHAMA PATEL: Open Payments
NPI 1770180135 · DUNELLEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 24 payments from 14 companies in 2025. Trend: 2023 $315 · 2024 $166 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $72 |
| ABBVIE INC. | 4 | $70 |
| ALK-Abello, Inc | 2 | $40 |
| Lundbeck LLC | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| PFIZER INC. | 2 | $36 |
| Exact Sciences Corporation | 1 | $26 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Becton, Dickinson and Company | 1 | $18 |
Products named: QULIPTA, NEFFY, REXULTI, Ozempic, JARDIANCE, PREVNAR 20, Cologuard Collection Kit, FANAPT.
Industry payments across NJ — which companies pay providers there.
